Who will have the final say on whether Ramsay Health Care leaves the ASX?

A look at the largest shareholders in the Aussie healthcare giant…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Excitement has returned to the Ramsay Health Care Limited (ASX: RHC) share price amid a $20 billion takeover bid.

The news hitting the headlines yesterday was met with eagerness as investors snapped up shares in the healthcare giant. In turn, the $88 per share offer made by the KKR consortium reignited the Ramsay fuse — converting the share price from a dormant slow mover into a flaring firecracker.

As the two conduct their due diligence, a major Ramsay shareholder is said to have already thrown their support behind the deal. However, with ASX-listed Ramsay Health Care shares having been out of the limelight for a while, onlookers might be wondering: Who are the major shareholders in Ramsay Health Care?

Let's take a look.

A worried doctor looks through a glass door.

Image source: Getty Images

Standing in the way of a $20 billion payday

There are plenty of hurdles to be cleared before the indicative proposal reaches Ramsay shareholders. Currently, the process is still in the first innings, with satisfactory due diligence yet to be finalised.

However, assuming the scheme arrangement ticks all the other boxes, including approval by the Foreign Investment Review Board, then shareholders of Ramsay Health Care will have the final say. So, what does the share registry look like?

The five largest shareholders in ASX-listed Ramsay Health Care hold roughly 30.5% of the total equity in the company. It stands to reason that these shareholders will play an important role in approving the bid.

Notably, the largest shareholder is Paul Ramsay Holdings Pty Ltd, with an 18.88% shareholding. The holding company contains the late founder's shares. These shares, valued at more than $3 billion, are held as a bequest to the Paul Ramsay Foundation.

The other four largest shareholders are as follows:

  • BlackRock Inc – 5.05%
  • The Vanguard Group Inc – 3.73%
  • Michael Siddle – 1.71%
  • Norges Bank Investment Management – 1.15%

How many retail investors hold Ramsay Health Care on the ASX?

While it appears that the power of the decision lies in the hands of a few large investment banks and a foundation, there are still plenty of retail investors on board as well.

At the time of writing, the general public constituted 61.5% of ownership in Ramsay Health Care. That means as a cohort, retail investors will hold more say in the final decision than the top five largest shareholders.

As an ASX-listed investment, Ramsay Health Care shares have returned 24.5% over the past five years. This is beefed up from 12.6% thanks to the contribution made by dividends.

Motley Fool contributor Mitchell Lawler has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Ramsay Health Care Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

Man with a sleep apnoea mask on whilst sleeping.
Healthcare Shares

Why ResMed shares are tumbling 6% today despite strong results

Here's what spooked investors.

Read more »

Scientist looking at a laptop thinking about the share price performance.
Healthcare Shares

Imricor Medical Systems shares: Philips declares compatibility for iMR products

Big news is catching the eye of investors on Friday.

Read more »

Broker looking at the share price on her laptop with green and red points in the background.
Earnings Results

ResMed posts strong Q4 earnings, lifts dividend

The sleep disorder treatment company had another record quarter.

Read more »

a doctor wearing a white coat with a stethoscope around her neck stares out a window with her hand to the side of her face as though in deep thought.
Healthcare Shares

Clarity Pharmaceuticals reports clinical trial milestones

Clarity Pharmaceuticals reported continued clinical progress for its prostate cancer imaging and therapy programs.

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Healthcare Shares

Are Neuren Pharmaceuticals shares a buy, hold or sell after rocketing 16%?

This healthcare stock keeps rising.

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Broker Notes

Up 64%, 3 reasons this expert predicts Pro Medicus shares will keep on giving

A leading expert forecasts more outperformance from the surging Pro Medicus share price.

Read more »

a biomedical researcher sits at his desk with his hand on his chin, thinking and giving a small smile with a microscope next to him and an array of test tubes and beackers behind him on shelves in a well-lit bright office.
Healthcare Shares

Clarity Pharmaceuticals reports new SECuRE trial responses at higher dose

Clarity Pharmaceuticals reports further progress in its SECuRE prostate cancer trial, showing strong PSA responses and new complete responses at…

Read more »

Two lab workers fist pump each other.
Healthcare Shares

Neuren Pharmaceuticals share price rockets: record Q2 DAYBUE sales and royalty upgrade

Second quarter net sales of DAYBUE increased 30%.

Read more »